Tag / Supreme Court
-
Policy Volatility, Abortion Access, and the Erosion of Trust in Healthcare
A federal appeals court recently restricted access to the most commonly used medication abortion drug – Mifepristone — via mail before the Supreme Court temporarily restored broader access while it considers the case, leaving the ultimate outcome uncertain and leaving the public unsure and anxious. We explores the many ways instability in access to the drug creates avoidable harms and, ultimately, erodes public trust in healthcare. The Center for Practical Bioethics.
-
2019 Flanigan Lecture MP3
Robert St. Peter, MD, president and CEO of the Kansas Health Institute, addresses some of the uncertainties that arose with the Supreme Court’s upholding of the Affordable Care Act
-
Healthcare Reform and Healthcare Foundations
Healthcare reform took a giant step forward with the Affordable Care Act, but Steve Roling, president and CEO of the Health Care Foundation
-
A Health Reform Perspective from Kansas
Robert St. Peter, MD, president and CEO of the Kansas Health Institute, addresses some of the uncertainties that arose
